Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma

Sasaki R, Kanda T, Yokosuka O, Kato N, Matsuoka S, Moriyama M. Exosomes and hepatocellular carcinoma: from bench to bedside. Int J Mol Sci 2019;20:E1406. https://doi.org/10.3390/ijms20061406 (PMID: 30897788) Yan Y, Lu Y, Mao K, Zhang M, Liu H, Zhou Q, et al. Identification and validation of prognostic 4 genes signature for hepatocellular carcinoma: integrated ceRNA network analysis. Hepatol Int 2019. https://doi.org/10.1007/s12072-019-09962-3 (Epub ahead of print, PMID: 31321712) Shiino S, Matsuzaki J, Shimomura A, Kawauchi J, Takizawa S, Sakamoto H, et al. Serum miRNA-based prediction of axillary lymph node metastasis in breast cancer. Clin Cancer Res 2019;25:1817–1827. https://doi.org/10.1158/1078-0432.ccr-18-1414 (PMID: 30482779) Yang YF, Pan YH, Cao Y, Fu J, Yang X, Zhang MF, et al. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-catenin signaling in hepatocellular carcinoma. Oncotarget 2017;8:47195–47205. https://doi.org/10.18632/oncotarget.17587 (PMID: 28525379) Yang QX, Zhong S, He L, Jia XJ, Tang H, Cheng ST, et al. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway. Cancer Lett 2019;452:90–102. https://doi.org/10.1016/j.canlet.2019.03.028 (PMID: 30914208) Mao J, Tian Y, Wang C, Jiang K, Li R, Yao Y, et al. CBX2 Regulates proliferation and apoptosis via the phosphorylation of YAP in hepatocellular carcinoma. J Cancer 2019;10:2706–2719. https://doi.org/10.7150/jca.31845 (PMID: 31258779) Smits VAJ, Cabrera E, Freire R, Gillespie DA. Claspin—checkpoint adaptor and DNA replication factor. FEBS J 2019;286:441–455. https://doi.org/10.1111/febs.14594 (PMID: 29931808) Choi SH, Yang H, Lee SH, Ki JH, Nam DH, Yoo HY. TopBP1 and claspin contribute to the radioresistance of lung cancer brain metastases. Mol Cancer 2014;13:211. https://doi.org/10.1186/1476-4598-13-211 (PMID: 25216549) Zou CD, Zhao WM, Wang XN, Li Q, Huang H, Cheng WP, et al. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma. Oncotarget 2016;7:266–278. https://doi.org/10.18632/oncotarget.5689 (PMID: 26497556) Murata K, Saito A, Katagiri S, Ariizumi S, Nakano M, Yamamoto M. Association of des-γ-carboxy prothrombin production and sonazoid-enhanced ultrasound findings in hepatocellular carcinomas of different histologic grades. J Med Ultrason (2001) 2018;45:223–229. https://doi.org/10.1007/s10396-017-0816-3 (PMID: 28828695) Hamaoka M, Kobayashi T, Tanaka Y, Mashima H, Ohdan H. Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: a prospective study. PLoS One 2019;14:e0217586. https://doi.org/10.1371/journal.pone.0217586 (PMID: 31141571)